• to lower the potential risk of severe cardiovascular (coronary heart and blood vessel) problems in Grownups with sort 2 diabetes and cardiovascular diseaseCalifornia biotech behemoth Amgen ditched ideas for an experimental weight loss capsule in May perhaps but is still hoping for the slice of the industry with MariTide, a month to month inject